Mary Beth Tombes
- Co-authors
- Dona AlbertiR Z ArzoomanianBetty B. GallucciDavid R. SpriggsGeorge WildingHoward H. BaileyRíona MulcahyK D Tutsch
- Topics
- Histone Deacetylase Inhibitors Research (13 papers)Acute Myeloid Leukemia Research (10 papers)Chronic Lymphocytic Leukemia Research (9 papers)
- Cited by
- OncologyBiochemistryHematology
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Mary Beth Tombes
36 papers receiving 704 citations
Peers
Comparison fields: 5 of 101
- Molecular Biology 373
- Oncology 212
- Immunology 97
- Pulmonary and Respiratory Medicine 81
- Cancer Research 73
Countries citing papers authored by Mary Beth Tombes
This map shows the geographic impact of Mary Beth Tombes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Beth Tombes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Beth Tombes more than expected).
Fields of papers citing papers by Mary Beth Tombes
This network shows the impact of papers produced by Mary Beth Tombes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Beth Tombes. The network helps show where Mary Beth Tombes may publish in the future.
Co-authorship network of co-authors of Mary Beth Tombes
This figure shows the co-authorship network connecting the top 25 collaborators of Mary Beth Tombes. A scholar is included among the top collaborators of Mary Beth Tombes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Beth Tombes. Mary Beth Tombes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 14 | |
| 3 | 8 | |
| 4 | 4 | |
| 5 | 8 | |
| 6 | 26 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 9 | |
| 10 | 3 | |
| 11 | 5 | |
| 12 | 13 | |
| 13 | 26 | |
| 14 | 14 | |
| 15 | 23 | |
| 16 | Phase Ib trial of bryostatin 1 in patients with refractory malignancies. | 46 |
| 17 | 161 | |
| 18 | 2 | |
| 19 | 18 | |
| 20 | Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusion. | 9 |
About Mary Beth Tombes
Mary Beth Tombes is a scholar working on Hematology, Genetics and Oncology, having authored 36 papers that have together received 720 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (13 papers), Acute Myeloid Leukemia Research (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). The work is most often cited by research in Oncology (212 citations), Biochemistry (50 citations) and Hematology (65 citations). Mary Beth Tombes has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Dona Alberti, R Z Arzoomanian, Betty B. Gallucci, David R. Spriggs, George Wilding, Howard H. Bailey, Ríona Mulcahy, K D Tutsch, Marcia Pomplun and John D. Roberts. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.